CA9 and nonpapillary renal cell carcinoma: Parallel to the different sunitinib response the models differed substantially in the accumulation of cG250, a monoclonal antibody targeting Carbonic anhydrase IX (CAIX) which is highly expressed in clear cell RCC (ccRCC) [11].